Jason V. Coloma, Chief Executive Officer at Maze Therapeutics, Inc. (MAZE), sold 34,501 shares at $26.31 ($907K) on 2026-09-01, disclosed to the SEC on 2026-09-03.
Scheduled sale ($907k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.29 | 31,908 | $839K | 92.5% |
| 2 | $26.31 | 2,593 | $68K | 7.5% |
| Total | $26.29 avg | 34,501 | $907K | 100% |
| Filing → |
| MAZE | SELL | 2026-07-02 | $1.0M | — | Filing → |
| MAZE | SELL | 2026-06-24 | $725K | — | Filing → |
| MAZE | SELL | 2026-06-03 | $174K | — | Filing → |